xml version="1.0" encoding="utf-8" ?   8-K    

   0000010456 BAX BAX (NYSE) false        0000010456   2020-02-21 2020-02-21     0000010456  exch:XCHI us-gaap:CommonStockMember    2020-02-21 2020-02-21     0000010456  exch:XNYS us-gaap:CommonStockMember    2020-02-21 2020-02-21     0000010456  bax:OnePointThreeZeroPercentageSeniorNotesDueMayTwoThousandAndTwentyFiveMember    2020-02-21 2020-02-21     0000010456  bax:OnePointThreePercentageSeniorNotesDueMayTwoThousandTwentyNineMember    2020-02-21 2020-02-21     0000010456  bax:ZeroPointFourPercentageSeniorNotesDueMayTwoThousandTwentyFourMember    2020-02-21 2020-02-21      

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT 

Pursuant to Section 13 or 15(d) 

of the Securities Exchange Act of 1934 

Date of Report (Date of earliest event reported): February 21, 2020

Baxter International Inc. 

(Exact name of registrant as specified in its charter)

  [DATA_TABLE_REMOVED] [DATA_TABLE_REMOVED]

Registrant’s telephone number, including area code: (224) 948-2000

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

  ☐ 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

  ☐ 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

  ☐ 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

  ☐ 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act: [DATA_TABLE_REMOVED]

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 Item 8.01 

Other Events. 

On February 21, 2020, Baxter International Inc. (“Baxter” or the “Company”) entered into Amendment No. 1 to its existing $2.0 billion, five-year revolving credit agreement, dated as of December 20, 2019, with JPMorgan Chase Bank, National Association, as Administrative Agent, and the various lenders thereto. The amendment provides an extension of the required delivery date for the Company’s (i) quarterly financial statements, with respect to the fiscal quarter ended September 30, 2019, and (ii) annual financial statements, with respect to the year ended December 31, 2019, in each case to March 31, 2020. 

Additionally, on the same date, the Company entered into Amendment No. 1 to its guaranty (the “Guaranty”) of Baxter Healthcare SA’s and Baxter World Trade SPRL’s existing €200 million, five-year revolving credit agreement, dated as of December 20, 2019, with J.P. Morgan Europe Limited, as Administrative Agent, and the various lenders thereto. The amendment to the Guaranty provides the same extension of the required delivery dates for the Company’s quarterly financial statements (with respect to the fiscal quarter ended September 30, 2019) and annual financial statements (with respect to the fiscal year ended December 31, 2019) to March 31, 2020. 

 SIGNATURE 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. [DATA_TABLE_REMOVED]